Delivery Order SPE2DX15D6044-SPE2DX24FCPUQ
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,413.28, is for the delivery of Timolol 0.5% gel-solution, a prescription eye drop medication. The contract has an ultimate completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $1,362.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop, to support military healthcare programs. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract,...
- This federal contract award, valued at $24,421.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Timolol 0.5% Gel-Solution, a prescription eye drop medication, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop medication, with a ceiling value of $3,363.12 and a period of performance through March 7, 2025. The contract is a firm fixed price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,066.05, is for the delivery of Timolol 0.25% Gel-Solution 5ML, a specialty medication used in the treatment of certain eye conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on March 10, 2025. AmerisourceBergen holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.25% Gel-Solution, a medical eye drop product, with a ceiling value of $9,324.26 and an ultimate completion date of February 7, 2024. The contract is a firm fixed-price agreement, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,413.66, is for the procurement of Timolol 0.25% Gel-Solution 5ML, a medication used to treat certain eye conditions. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Timolol 0.5% gel-solution, a prescription eye drop medication. The $2,362.48 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is for the delivery of Timolol 0.5% Gel-Solution, a prescription eye medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,356.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
- SPE2DX15D6044Indefinite Delivery Contract
- SPE2DX15D6044-SPE2DX24FCPUQDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,617.93, is for the delivery of Timolol 0.25% Gel-Solution 5ML, a prescription eye drop medication. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor for this award, and no major subcontractors are mentioned. The contract type is Firm Fixed Price, with an ultimate completion date of December 18, 2023.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.6k | 12/15/23 |